Betel Del Rosario García

5PUBLICATIONS
8CO-AUTHORS
Aboriginal and Torres Strait Islander genomicsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 28, 2026
Impact of UGT1A1*28 Allele on the Safety and Effectiveness of Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer: Real-World Evidence.

Fernando do Pazo-Oubiña, Betel Del Rosario García, Marta Miarons

|Sep 25, 2023
Risk factors determining adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia.

Betel Del Rosario García, María Micaela Viña Romero, Virginia González Rosa

|Dec 09, 2022
Imatinib plasma levels in patients with gastrointestinal stromal tumour under routine clinical practice conditions.

Betel Del Rosario García, José Alberto Morales Barrios, Josefina Cruz Jurado

|Oct 18, 2021
Imatinib plasma levels in patients with chronic myeloid leukaemia under routine clinical practice conditions.

Betel Del Rosario García, Iris González García, María Micaela Viña Romero

|Mar 01, 2021
Patient-reported outcomes and digital literacy of patients treated in an oncology day hospital unit.

Betel Del Rosario García, José Alberto Morales Barrios, María M Viña Romero

Pageof 1

Frequent Collaborators

4 joint publications

Ruth Ramos Díaz

2 joint publications

Ivette Mourani Padrón

1 joint publications

Jonathan González García

1 joint publications

Fernando do Pazo-Oubiña